M&A TRANSACTION · 2019
Consort Medical plc acquired by Recipharm
$649.0M· 9.2x EBITDA· 1.60x revenue
Target
Consort Medical plc
Acquirer
Recipharm
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$399.7M
EBITDA
$70.9M
Deal Value
$649.0M
EV/EBITDA
9.2x
Context
This $649.0M acquisition of Consort Medical plc by Recipharm sits in the medical devices sub-vertical. The 9.2x EBITDA multiple paid in 2019 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Recipharm is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from Press releases and financial statements. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Consort Medical plc acquisition.